SECTORAL ASSET MANAGEMENT INC — 13F Holdings & Portfolio
CIK 1274413 · latest 13F-HR filed 2026-05-15
SECTORAL ASSET MANAGEMENT INC manages $120.7M in 13F-reported U.S. long-equity assets across 77 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are EVMN (11.22%), CTNM (7.87%), SI (5.18%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 10 new positions, exited 7, added to 17, and trimmed 43.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$120.7M
Long-equity book
77
Distinct positions
2026-03-31
Filed 2026-05-15
+10 / −7 / ↑17 / ↓43
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- EVOMMUNE INC$3.5M +34.3%
- GILEAD SCIENCES INC$1.9M +88.2%
- INSMED INC$1.4M +73.7%
- BIONTECH SE$406.2K +24.8%
- MERCK & CO INC$331.3K +14.7%
Top Trims
- ELI LILLY & CO-$2.0M -25.3%
- ABBVIE INC-$1.2M -30.9%
- STRUCTURE THERAPEUTICS-$949.5K -57.2%
- SHOULDER INNOVATIONS-$788.0K -11.2%
- VERA THERAPEUTICS-$781.8K -41.9%
New Positions
- IQVIA HOLDINGS INC$1.4M
- BRISTOL MYERS SQUIBB$1.3M
- MEDTRONIC PLC$961.8K
- ARDELYX INC$781.1K
- AGOMAB THERAPEUTICS$477.3K
Exited Positions
- ASTRAZENECA$1.4M
- VENTYX BIOSCIENCES$875.4K
- LENZ THERAPEUTICS INC$680.0K
- AMICUS THERAPEUTICS$616.6K
- CARLSMED INC$589.1K
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | EVOMMUNE INC | EVMN | 30054Y107 | $13.5M | 11.22% | 589,005 | SH |
| 2 | CONTINEUM THERAPEUTICS | CTNM | 21217B100 | $9.5M | 7.87% | 727,587 | SH |
| 3 | SHOULDER INNOVATIONS | SI | 82537J108 | $6.3M | 5.18% | 430,407 | SH |
| 4 | ELI LILLY & CO | LLY | 532457108 | $5.8M | 4.84% | 6,354 | SH |
| 5 | JOHNSON & JOHNSON | JNJ | 478160104 | $4.5M | 3.69% | 18,218 | SH |
| 6 | GILEAD SCIENCES INC | GILD | 375558103 | $4.1M | 3.42% | 27,490 | SH |
| 7 | UNITEDHEALTH GRP INC | UNH | 91324P102 | $4.0M | 3.35% | 14,957 | SH |
| 8 | AMGEN INC | AMGN | 031162100 | $3.5M | 2.91% | 9,210 | SH |
| 9 | VERTEX PHARMA | VRTX | 92532F100 | $3.5M | 2.86% | 7,007 | SH |
| 10 | INSMED INC | INSM | 457669307 | $3.4M | 2.80% | 19,668 | SH |
| 11 | ARGENX SE | ARGX | 04016X101 | $2.7M | 2.27% | 3,564 | SH |
| 12 | ABBVIE INC | ABBV | 00287Y109 | $2.7M | 2.20% | 12,200 | SH |
| 13 | ABBOTT LABS | ABT | 002824100 | $2.6M | 2.18% | 25,578 | SH |
| 14 | MERCK & CO INC | MRK | 58933Y105 | $2.6M | 2.14% | 21,480 | SH |
| 15 | REGENERON PHARMCTCLS | REGN | 75886F107 | $2.5M | 2.06% | 2,919 | SH |
| 16 | INTUITIVE SURGIC INC | ISRG | 46120E602 | $2.4M | 2.00% | 5,250 | SH |
| 17 | BOSTON SCIENTIFIC | BSX | 101137107 | $2.2M | 1.81% | 34,780 | SH |
| 18 | BIONTECH SE | BNTX | 09075V102 | $2.0M | 1.69% | 22,164 | SH |
| 19 | STRYKER CORP | SYK | 863667101 | $1.9M | 1.60% | 5,874 | SH |
| 20 | DANAHER CORP | DHR | 235851102 | $1.8M | 1.51% | 9,597 | SH |
| 21 | THERMO FISHER SCIENTIFIC | TMO | 883556102 | $1.7M | 1.43% | 3,508 | SH |
| 22 | DEXCOM INC | DXCM | 252131107 | $1.5M | 1.21% | 23,231 | SH |
| 23 | IQVIA HOLDINGS INC | IQV | 46266C105 | $1.4M | 1.17% | 8,307 | SH |
| 24 | SUMMIT THERAPEUTICS | SMMT | 86627T108 | $1.4M | 1.16% | 69,615 | SH |
| 25 | EDWARDS LIFESCIENCES | EW | 28176E108 | $1.4M | 1.15% | 17,338 | SH |
| 26 | BRISTOL MYERS SQUIBB | BMY | 110122108 | $1.3M | 1.06% | 21,150 | SH |
| 27 | UNITED THERAPEUTICS | UTHR | 91307C102 | $1.1M | 0.95% | 1,710 | SH |
| 28 | VERA THERAPEUTICS | VERA | 92337R101 | $1.1M | 0.90% | 25,573 | SH |
| 29 | ARCUS BIOSCIENCES | RCUS | 03969F109 | $1.0M | 0.86% | 45,070 | SH |
| 30 | ROIVANT SCIENCES LTD | ROIV | G76279101 | $1.0M | 0.84% | 32,500 | SH |
| 31 | MEDTRONIC PLC | MDT | G5960L103 | $961.8K | 0.80% | 11,100 | SH |
| 32 | TREVI THERAPEUTICS | TRVI | 89532M101 | $939.5K | 0.78% | 74,446 | SH |
| 33 | COGENT BIOSCIENCES | COGT | 19240Q201 | $902.4K | 0.75% | 22,140 | SH |
| 34 | MINERALYS THERAPEUTICS | MLYS | 603170101 | $895.1K | 0.74% | 31,618 | SH |
| 35 | ALNYLAM PHARMACUETCL | ALNY | 02043Q107 | $864.2K | 0.72% | 2,310 | SH |
| 36 | TARSUS PHARMACEUTICALS | TARS | 87650L103 | $852.5K | 0.71% | 11,272 | SH |
| 37 | RAPPORT THERAPEUTICS | RAPP | 75383L102 | $835.0K | 0.69% | 25,421 | SH |
| 38 | NEKTAR THERAPEUTICS | NKTR | 640268306 | $820.7K | 0.68% | 10,851 | SH |
| 39 | SYNDAX PHARMACEUTICS | SNDX | 87164F105 | $787.5K | 0.65% | 31,680 | SH |
| 40 | ARDELYX INC | ARDX | 039697107 | $781.1K | 0.65% | 122,394 | SH |
| 41 | PFIZER INC | PFE | 717081103 | $772.2K | 0.64% | 27,500 | SH |
| 42 | BOUNDLESS BIO | BOLD | 10170A100 | $746.4K | 0.62% | 678,574 | SH |
| 43 | ASCENDIS PHARMA A S | ASND | 04351P101 | $728.3K | 0.60% | 2,800 | SH |
| 44 | ARRIVENT BIOPHARMA | AVBP | 04272N102 | $720.4K | 0.60% | 30,013 | SH |
| 45 | STRUCTURE THERAPEUTICS | GPCR | 86366E106 | $710.8K | 0.59% | 14,102 | SH |
| 46 | IMMATICS NV | IMTX | N44445109 | $692.7K | 0.57% | 66,830 | SH |
| 47 | BRIDGEBIO PHARMA | BBIO | 10806X102 | $687.3K | 0.57% | 8,100 | SH |
| 48 | ARS PHARMACEUTICALS | SPRY | 82835W108 | $676.7K | 0.56% | 79,150 | SH |
| 49 | BEONE MEDICINES LTD | ONC | 07725L102 | $631.1K | 0.52% | 1,870 | SH |
| 50 | TECTONIC THERAPEUTIC | TECX | 878972108 | $628.2K | 0.52% | 19,059 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $120.7M | 77 | 0001104659-26-062046 |
| 2025-12-31 | 2026-02-09 | $124.8M | 74 | 0001104659-26-011921 |
| 2025-09-30 | 2025-11-14 | $162.0M | 82 | 0001104659-25-112082 |